Compare POM & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POM | IINN |
|---|---|---|
| Founded | 2015 | 2018 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.8M | 35.3M |
| IPO Year | 2025 | 2021 |
| Metric | POM | IINN |
|---|---|---|
| Price | $0.30 | $0.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | ★ 1.3M | 177.1K |
| Earning Date | 12-03-2025 | 10-01-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $51,210,721.00 | $289,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2,582.74 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.13 | N/A |
| 52 Week Low | $0.26 | $0.40 |
| 52 Week High | $6.43 | $1.65 |
| Indicator | POM | IINN |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 38.67 |
| Support Level | N/A | $0.92 |
| Resistance Level | N/A | $1.01 |
| Average True Range (ATR) | 0.00 | 0.06 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 0.00 | 5.42 |
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.